{"id":"W2898376257","doi":"10.1093/annonc/mdy424.043","title":"Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab in patients with advanced recurrent ovarian cancer: Results from the phase II KEYNOTE-100 study","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Merck Sharp and Dohme; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Eisai; Merck","keywords":"Medicine; Pembrolizumab; Ovarian cancer; Internal medicine; Oncology; BRCA mutation; Population; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001668947,0.0003656651,0.00065236,0.000244281,0.0001770969,0.0005516662,0.0003529549,0.0004794859,0.001071649],"category_scores_gemma":[0.001326653,0.0002219306,0.000443627,0.0003630781,0.0002769631,0.0003333176,0.0002876063,0.0006965144,0.0002475117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004780049,"about_ca_system_score_gemma":0.0003260722,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003423799,"about_ca_topic_score_gemma":0.0006578818,"domain_scores_codex":[0.9995751,0.0001747223,0.00003598267,0.0001054897,0.00006926838,0.00003951377],"domain_scores_gemma":[0.9990908,0.0002388379,0.0003001833,0.00008530757,0.00008119529,0.000203734],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1064523,0.003615155,0.7862681,0.0004882826,0.002168378,0.0002195109,0.0002271209,0.001522981,0.04586281,0.0000685489,0.002335923,0.05077101],"study_design_scores_gemma":[0.01250581,0.02776508,0.9492571,0.00003120368,0.0009774717,0.0006993407,0.00009714389,0.001649275,0.00432989,0.0000852033,0.002575236,0.0000274192],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979134,0.0007539698,0.0001233548,0.00007031349,0.000005349762,0.00007821625,0.0007521195,0.00001192585,0.0002913487],"genre_scores_gemma":[0.9968048,0.0002187271,0.0002538753,0.0001560651,0.00001892089,0.0001031201,0.002196161,0.000005254512,0.0002431684],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001668947,"threshold_uncertainty_score":0.008826315,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06020003525901501,"score_gpt":0.4252376011103097,"score_spread":0.3650375658512947,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}